Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po


Iskalni niz: "ključne besede" (women) .

1 - 3 / 3
Na začetekNa prejšnjo stran1Na naslednjo stranNa konec
The muscle contractile properties in female soccer players : inter-limb comparison using tensiomyography
Armin Paravlić, Zoran Milanović, Ensar Abazović, Goran Vučković, Darjan Spudić, Živa Majcen Rošker, Maja Pajek, Janez Vodičar, 2022, izvirni znanstveni članek

Povzetek: Objective: The present study aimed to: i) determine the contractile properties of the major lower limb muscles in female soccer players using tensiomyography; ii) investigate inter-limb differences; and iii) compare inter-limb differences between different selections and playing positions. Methods: A total of 52 female soccer players (A team; U19 and U17) were recruited. The vastus lateralis (VL), vastus medialis (VM), rectus femoris (RF), biceps femoris (BF), gastrocnemius medialis (GM), lateralis (GL) and tibialis anterior (TA) of both lower limbs were evaluated. Results: When the entire sample was assessed regardless of selection or playing position, there were significant inter-limb differences in all measured muscles except BF. Compared to the non-dominant limb, the dominant limb had higher delay time in VL (p=0.008), while showing lower values in VM (p=0.023), GL (p=0.043) and GM (p=0.006). Contraction time was lower in the RF of the dominant limb (p=0.005) and VM (p=0.047), while showing higher values in VL (p=0.036) and TA (p<0.001) as compared to the non-dominant limb. Conclusion: Given the differences found between the limbs in the whole sample studied, it is necessary to examine both limbs to gather a more in-depth understanding of underlying mechanisms related to neuromuscular functions in female soccer players. Level of evidence: Prognostic study, Level II.
Ključne besede: asymmetries, neuromuscular functions, skeletal muscles, tensiomyography, Women' s football
Objavljeno v DiRROS: 16.06.2022; Ogledov: 100; Prenosov: 52
.pdf Celotno besedilo (649,20 KB)
Gradivo ima več datotek! Več...

Christian-Muslim women in religious peacebuilding, breaking cycles of violence
Nadja Furlan-Štante, 2020, izvirni znanstveni članek

Povzetek: In a broader context, the main focus of this paper is the question of wom-en%s religious peacebuilding, which is understood in its widest sense, in terms of women%s active participation in building liberating theologies and societies. It is about the promotion of the full humanity of women. While elaborating this theme, the paper takes up Susan Brooks Thistlethwaite%s assertion that the %violence against women is the largest and longest global war.% Just peacemak-ing is very much an interfaith and interreligious work and should be placed as a crucial starting point of the urge for transformation of %violent% theologies and living everyday praxis. While women have been marginalised from peacebuild-ing generally, the emerging field of religious peacebuilding has been particularly challenging for women. The liberating theme of this paper is illumination of the ambivalence of invisibility and marginality of women in religious peacebuilding, good practices and future issues.
Ključne besede: religion, women, religious peace-building, interreligious dialogue, obstacles, good practices
Objavljeno v DiRROS: 28.03.2022; Ogledov: 125; Prenosov: 86
.pdf Celotno besedilo (119,04 KB)
Gradivo ima več datotek! Več...

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling : a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials
2019, izvirni znanstveni članek

Povzetek: Background: Increasing the dose intensity of cytotoxic therapy by shortening the intervals between cycles, or by giving individual drugs sequentially at full dose rather than in lower-dose concurrent treatment schedules, might enhance efficacy. Methods: To clarify the relative benefits and risks of dose-intense and standard-schedule chemotherapy in early breast cancer, we did an individual patient-level meta-analysis of trials comparing 2-weekly versus standard 3-weekly schedules, and of trials comparing sequential versus concurrent administration of anthracycline and taxane chemotherapy. The primary outcomes were recurrence and breast cancer mortality. Standard intention-to-treat log-rank analyses, stratified by age, nodal status, and trial, yielded dose-intense versus standard-schedule first-event rate ratios (RRs). Findings: Individual patient data were provided for 26 of 33 relevant trials identified, comprising 37,298 (93%) of 40,070 women randomised. Most women were aged younger than 70 years and had node-positive disease. Total cytotoxic drug usage was broadly comparable in the two treatment arms; colony-stimulating factor was generally used in the more dose-intense arm. Combining data from all 26 trials, fewer breast cancer recurrences were seen with dose-intense than with standard-schedule chemotherapy (10-year recurrence risk 28.0% vs 31.4%; RR 0.86, 95% CI 0.82-0.89; p<0.0001). 10-year breast cancer mortality was similarly reduced (18.9% vs 21.3%; RR 0.87, 95% CI 0.83-0.92; p<0.0001), as was all-cause mortality (22.1% vs 24.8%; RR 0.87, 95% CI 0.83-0.91; p<0.0001). Death without recurrence was, if anything, lower with dose-intense than with standard-schedule chemotherapy (10-year risk 4.1% vs 4.6%; RR 0.88, 95% CI 0.78-0.99; p=0.034). Recurrence reductions were similar in the seven trials (n=10,004) that compared 2-weekly chemotherapy with the same chemotherapy given 3-weekly (10-year risk 24.0% vs 28.3%; RR 0.83, 95% CI 0.76-0.91; p<0.0001), in the six trials (n=11,028) of sequential versus concurrent anthracycline plus taxane chemotherapy (28.1% vs 31.3%; RR 0.87, 95% CI 0.80-0.94; p=0.0006), and in the six trials (n=6532) testing both shorter intervals and sequential administration (30.4% vs 35.0%; RR 0.82, 95% CI 0.74-0.90; p<0.0001). The proportional reductions in recurrence with dose-intense chemotherapy were similar and highly significant (p<0.0001) in oestrogen receptor (ER)-positive and ER-negative disease and did not differ significantly by other patient or tumour characteristics. Interpretation: Increasing the dose intensity of adjuvant chemotherapy by shortening the interval between treatment cycles, or by giving individual drugs sequentially rather than giving the same drugs concurrently, moderately reduces the 10-year risk of recurrence and death from breast cancer without increasing mortality from other causes.
Ključne besede: breast neoplasms, women, drug therapy, clinical protocols, meta-analysis, breast cancer, chemotherapy, treatment schedule, randomized trials
Objavljeno v DiRROS: 22.10.2020; Ogledov: 780; Prenosov: 498
.pdf Celotno besedilo (822,68 KB)
Gradivo ima več datotek! Več...

Iskanje izvedeno v 0.23 sek.
Na vrh